Open Access Article
Eunji
Jeong
a,
Seo Yeong
Oh
b,
Seong Uk
Son
bc,
Sojeong
Lee
a,
Ryunhyung
Kim
a,
Jaewook
Lim
a,
Sunjoo
Kim
d,
Taejoon
Kang
be,
Juyeon
Jung
bce,
Seung-Yong
Seong
fghi,
In-Young
Jang
i,
Jong Hyun
Kim
i,
Eunhee
Jang
j,
Hyoung Hwa
Jeong
j,
Eun-Kyung
Lim
*bce and
Seungjoo
Haam
*a
aDepartment of Chemical and Biomolecular Engineering, Yonsei University, Seoul 03722, Republic of Korea. E-mail: haam@yonsei.ac.kr
bBionanotechnology Research Center Korea Research Institute of Bioscience and Biotechnology (KRIBB), Daejeon 34141, Republic of Korea. E-mail: eklim1112@kribb.re.kr
cDepartment of Nanobiotechnology, KRIBB School, University of Science and Technology (UST), 125 Gwahak-ro, Yuseong-gu, Daejeon 34113, Republic of Korea
dDepartment of Laboratory Medicine, Gyeongsang National University Changwon Hospital, Changwon 51472, Republic of Korea
eSchool of Pharmacy, Sungkyunkwan University, Suwon 16419, Republic of Korea
fWide River Institute of Immunology, Seoul National University College of Medicine, Hongchon 25159, Republic of Korea
gDepartment of Microbiology and Immunology, Seoul National University College of Medicine, Seoul 03080, Republic of Korea
hDepartment of Biomedical Sciences, Seoul National University College of Medicine, Seoul 03080, Republic of Korea
iShaperon, Inc., Seoul 06373, Republic of Korea
jResearch Center, HuVet bio, Inc., Seoul 05836, Republic of Korea
First published on 8th December 2025
Correction for ‘Nanobody engineering for enhanced-sensitivity rapid COVID-19 tests’ by Eunji Jeong et al., Nanoscale, 2025, 17, 23329–23342, https://doi.org/10.1039/D5NR02568K.
The Royal Society of Chemistry apologises for these errors and any consequent inconvenience to authors and readers.
| This journal is © The Royal Society of Chemistry 2026 |